Association between the MIF-173G/C Polymorphism and Serum MIF levels with Pulmonary Tuberculosis: A Meta-analysis

Area of Science:

• Immunogenetics
• Infectious Diseases
• Molecular Biology

Background:

• Macrophage migration inhibitory factor (MIF) plays a role in immune responses.
• Previous studies suggested associations between MIF gene polymorphisms and pulmonary tuberculosis (PTB) susceptibility, but results were inconclusive.
• Elevated serum MIF levels have been observed in PTB patients, though not consistently across all studies.

Purpose of the Study:

• To precisely evaluate the association between the MIF-173G/C gene polymorphism and serum MIF concentrations with PTB susceptibility.
• To clarify the role of MIF in PTB development and progression, especially in specific ethnic groups.

Main Methods:

• A systematic literature search was conducted to identify relevant studies.
• Eleven articles comprising 1316 PTB cases and 1272 controls were included in the meta-analysis.
• Statistical analysis was performed to assess the association between MIF-173G/C polymorphism, serum MIF levels, and PTB.

Main Results:

• The MIF-173G/C polymorphism showed a significant association with PTB susceptibility, particularly in Asian individuals.
• Circulating MIF levels were significantly higher in PTB patients compared to healthy controls, specifically within the Asian cohort.
• The findings remained statistically significant even when analyzing high-quality studies.

Conclusions:

• The MIF-173G/C polymorphism may contribute to the genetic susceptibility of developing PTB.
• Significantly elevated serum MIF levels in PTB patients suggest MIF's important role in disease progression, especially in Asians.
• Further research into MIF's function in PTB pathogenesis is warranted.